Correction to: Molecular Biology Reports (2023) 50:173–183.
10.1007/s11033-022-07907-y.
In the original form of the published article, the criteria for detection of neurologic syndrome in the COVID-19 subjects is missing.
Initially, 500 subjects with COVID-19 were recruited, among which 72 patients were diagnosed as having neurologic syndrome. The diagnosis was accomplished by a neurologist using a complete examination that involved several approaches:
Clinical assessment.
Detailed history: Information about the patient’s medical history, including any pre-existing neurological conditions were collected.
Symptom evaluation: The presence and nature of neurological symptoms, such as headache, delirium, dizziness, confusion, muscle weakness, and altered sensation were assessed.
Physical examination:
Neurological examination: A thorough neurological examination was performed to assess motor function, sensory function, reflexes, coordination, and cranial nerve function.
Diagnostic tests:
Imaging: Neuroimaging technique (brain MRI) was used to identify structural abnormalities, such as strokes, encephalitis, or other lesions.
Electroencephalogram (EEG): EEG was recorded to detect abnormal brain electrical activity, such as seizures or encephalopathy.
Footnotes
The online version of the original article can be found at 10.1007/s11033-022-07907-y.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Roghaiyeh Safari, Email: roghaiyeh.safari@gmail.com.
Hamed Mohammadi, Email: mohamadi.h86@gmail.com.